GET THE PREMIUM SUBSCRIPTION FREE FOR 14 DAYS!

Chiasma Company Profile

60 Wells Avenue

Newton MA 02459

866-637-9703

www.chiasmapharma.com

Industry: Biotechnology

Sector: Healthcare

Chiasma

Description

Chiasma, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing oral forms of therapies for patients suffering from orphan diseases. Its product candidate is octreotide capsules or MYCAPSSA, which has completed Phase III clinical trial for the treatment of acromegaly, a condition that results in the body’s production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Newton, Massachusetts.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE